Introduction
The trace element selenium is essential to human health in prevention of a number of degenerative conditions, as established during the last few decades [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . These conditions include cancer, thyroid function, aging, infertility, infections, and inflammatory, cardiovascular and neurological diseases. Selenium is acquired by human beings through the diet and involves several compounds: L-selenomethionine (SeMet), Se-methyl L-selenocysteine (MeSeCys), L-selenocysteine, selenite and selenate [17] [18] [19] [20] . Commercially available selenium supplements also contain these forms. It has been demonstrated that SeMet and MeSeCys are antioxidants with anticancer and cancer prevention properties [15, [21] [22] [23] [24] [25] [26] [27] . In addition, MeSeCys protects against oxidative stress caused by external oxidants or by γ-radiation [28, 29] . It offers selective protection against toxicity and potentiates the antitumor activity of some existing anticancer drugs, including cisplatin [30] .
Anticancer drug discovery studies based on the naturally occurring selenium compounds and investigations of their cancer prevention properties have been pursued vigorously during the last three decades [9] [10] [11] [12] [13] [14] [15] [16] . However, the anticancer or cancer prevention mechanisms of the selenium compounds are still not known in detail, and they seem to be highly dependent on the speciation of the compounds and the specific metabolic pathways of cell and diseases [14] . The three naturally available compounds SeMet, MeSeCys and selenite appear to be the most important selenium forms in cancer prevention [31, 32] . Although SeMet and MeSeCys have similar structures, they display disparate efficacies as anticancer agents [33, 34] , which is probably related to their different redox properties [14] [15] [16] . Significantly, MeSeCys has been found to be not very toxic to the normal human cells, conferring a possibility to achieve a therapeutic selenium window [15] .
Reduction of the Pt(IV) anticancer model compounds trans-[PtX 2 (CN) 4 ] 2− (X = Cl; Br) by SeMet has been characterized kinetically and mechanistically [35] . We here continue these studies with a comparative kinetic analysis on the reduction of the same Pt(IV) model compounds by MeSeCys. There is currently a strong interest in the development of Pt(IV)-based anticancer drugs in order to minimize the toxic effects of the existing platinum-based anticancer drugs and to expand their curing spectra [36] . C NMR spectra were recorded by use of a Bruker AVANCE III 600 MHz digital NMR spectrometer (Bruker Daltonics Inc., Billerica, MA, USA). High-resolution mass spectra were recorded on an Apex Ultra 7.0 T FT-ICR mass spectrometer (Bruker Daltonik, Germany) with an electrospray ionization (ESI) of positive mode. An Applied Photophysics SX-20 stopped-flow spectrometer (Applied Photophysics Ltd., Leatherhead, U.K.) was used for recording rapid scan spectra and for kinetic runs. UV-Vis spectra were recorded by use of a TU-1900 spectrophotometer (Beijing Puxi, Inc., Beijing, China) with 1.00 cm quartz cells. The pH values of buffer solutions (for pH N 3) were measured with an Accumet Basic AB15 Plus pH meter equipped with an Accumet combination pH electrode (Fisher Scientific, Pittsburgh, PA). Standard buffers of pH 4.00, 7.00 and 10.00 from Fisher Scientific were used to calibrate the electrode immediately before the pH measurements.
Reaction media
Buffer solutions containing 2 mM EDTA and 1.0 M ionic strength (μ) were prepared essentially in the same way described earlier [35] . When pH b 3, the reaction media containing 0.10 M NaX (X = Cl and Br) were prepared by combinations of 1.00 M HClO 4 , 1.00 M NaClO 4 , 0.10 M NaX was added to all solutions. 4 , 0.09 M NaX and 0.01 M HX; these solutions were wrapped with aluminum foil and kept in a refrigerator. Solutions of Pt(IV) complexes and of MeSeCys for kinetic measurements were prepared, respectively, by adding an appropriate amount of the Pt(IV) stock solution and of MeSeCys to a specific medium. Those solutions were flushed for 10 min with nitrogen before loading onto the stopped-flow instrument and were only used for a couple of hours. Reactions were initiated by mixing equal volumes of Pt(IV) and MeSeCys solutions directly in the stopped-flow spectrometer and were followed under pseudo first-order conditions with MeSeCys in at least 10-fold excess.
Kinetic measurements

Stoichiometric measurements
Spectrophotometric titration was used to study the reaction stoichiometry as described earlier [40] [41] [42] [43] in Fig. S2 in Supplementary Data. These spectra also display two welldefined isosbestic points at 244.2 and 286.1 nm (cf. Fig. S3 
The variation of k' with pH is summarized in Table S2 in Supplementary Data. 
Reaction stoichiometry and product identification
SeMet is often oxidized to its selenoxide form by various oxidants [35, [44] [45] [46] . In the case of MeSeCys, the oxidation product has been less extensively characterized. Therefore, high resolution mass spectra were recorded for two samples: one was 1.0 mM MeSeCys in 10 mM HCl and the other one was a reaction mixture of 1.0 mM MeSeCys and [46] ) are confirmed by the mass spectra. MeSe(OH) 2 Cys is expected to be formed after the rate-determiningsteps. Therefore, Eq. (2) is justified by the mass spectral analysis.
Reaction mechanism
The reaction parameters deduced for the present reaction systems, including the rapid scan spectra, the overall second-order kinetics, the k' versus pH profiles in Figs. 5 and 6, and the 1:1 redox stoichiometry are similar to those observed in the reduction of [PtX 2 (CN) 4 ] 2− by SeMet [35] . Therefore, a similar reaction mechanism, as the one depicted in Scheme 1, is anticipated for the present reaction systems also. The rate-determining reactions (denoted by k 1 -k 3 ) proceed via inner-sphere electron transfer mechanisms, leading to an X + transfer from the Pt(IV) complexes to the attacking selenium atom (cf. further discussion below). Eq. (3) will be the rate expression for k' derived from Scheme 1, where K a1 and K a2 are the protolysis constants of MeSeCys, and a H pertains to the proton activity, corresponding exactly to the measured pH values.
By use of a weighted non-linear least-squares method, Eq. (3) was employed to simulate the k' -pH dependence data in Fig. 5 for the reduction of the chloride complex, with k 1 -k 3 and K a1 and K a2 all as tunable parameters. No well defined pK a values at 25.0°C and 1.0 M ionic strength are available in the literature, only approximate values at undefined temperature and ionic strength (pK a1~2 and pK a2 = 8.8) were found [47] . The resulting good fit shown in Fig. 5 not only justifies the conformity of Eq. (3) to the k' -pH data but also affords well-defined pK a -values (pK a1 = 1.90 ± 0.15 and pK a2 = 8.74 ± 0.09) and the k 1 -k 3 values listed in Table 1 . The ratios k 2 /k 1 = 9 and k 3 /k 2 = 37 referring to the deprotonations of the -COOH and -NH 3 + groups in MeSeCys, respectively, confer very significant reactivity differences between the three protolytic species. The data in Fig. 6 refer to reduction of the bromide complex. It only involves the deprotonation of the carboxylic group in MeSeCys, since [PtBr 2 (CN) 4 ] 2− is only stable in acidic media, precluding kinetic data collection in neutral and basic media [38] . Accordingly, Eq. (3) is simplified to Eq. (4):
Eq. (4) was used to simulate the k' -pH dependence data given in Fig. 6 . It also results in a good fit and provides pK a1 = 2.12 ± 0.15 and the values of k 1 and k 2 listed in Table 1 . The agreement between the pK a1 values derived for the two Pt(IV) reactions is good within experimental errors.
Activation parameters
The species distribution diagram of MeSeCys versus pH was calculated by use of the pK a values derived here; in addition, the reactivity versus pH distribution diagram for the MeSeCys species was computed for the reaction of [PtCl 2 (CN) 4 ] 2− with MeSeCys utilizing the pK a values and the rate constants k 1 -k 3 (cf. the diagrams in Fig. S6 in Supplementary Data) [40, 42] . The diagrams show that in the region 3.5 b pH b 5, the zwitterionic form of MeSeCys (MeSeCH 2 CH(NH 3
) is the only species contributing both to the total population and to the total reactivity. Therefore, k' equals k 2 in Scheme 1 in this region. Temperature dependencies of k obsd in buffers of this region are shown in Fig. 2 , respectively. Table 2 summarizes the k 2 values at different temperatures. Activation parameters were evaluated from the perfectly linear Eyring plots (Fig. S7 in Supplementary Data) , and are also given in Table 2 .
Bridged two-electron transfer mode
The rate-determining steps of the reductive elimination reactions of trans-dihalido-Pt(IV) complexes have been interpreted to take place through an inner-sphere electron transfer, via a bridge formation between one of the axially coordinated halides of the platinum complexes and the attacking selenium atom of the reductants [35, 40, 48] . This mode of two-electron transfer predicts that a good bridging atom should favor the electron transfer. The derived rate constants in Table 1 [50] ). Thus, the obtained activation parameters strongly support the bridged electron transfer mode. To the best of our knowledge, this work, together with a previous one [35] , shows for the first time that an X + transfer from the oxidants to the selenium-containing compounds takes place.
Comparison of rate constants
Selenium compounds are often characterized by their strong antioxidant properties, which is linked essentially to their major biological roles [5, [51] [52] [53] . The reactivity of SeMet and MeSeCys in reducing some oxidants encountered in human bodies has been studied, including hydroxyl radicals (•OH) [47] , chlorine radicals (•Cl 2 − ) [47] and 
•mol hypothiocyanous acid (HOSCN) [51] . The reactivity ratios k'((SeMet)/ k'(MetSeCys) were found to be 0.9 for •OH at pH 1, 1.6 for •Cl 2 − at pH 1, and ≥6 for HOSCN at pH 7.4; the ratios for •OH and •Cl 2 − might be less accurate since the rate constants are close to the diffusion controlled ones.
The relative values of k 1 , k 2 and k 3 for MeSeCys show that the rates increase significantly as the charge becomes more negative, since in the rate-determining steps, the selenium atom is accommodating the positively charged X + . The trend becomes less pronounced in the case of SeMet where the charge effects are attenuated by the additional methylene group inserted between the Se atom and the charges. A comparison between the rate constants in Table 1 , MeSeCys and SeMet show similar kinetic and mechanistic characters, but there is a big reactivity difference. The difference is not only the largest one observed so far, but it is also dependent on the protolytic species of MeSeCys and SeMet. The reactivity difference observed here might be one reason for the different efficacies of these two selenium compounds as anticancer agents. Moreover, this kinetic analysis also offers novel values for the pK a values of MeSeCys at 25.0°C and 1.0 M ionic strength.
